Rebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett’s oesophagus
About this episode
Professor Rebecca Fitzgerald discusses her team's tool for improving surveillance of Barrett's oesophagus.
Early detection of oesophageal adenocarcinoma improves outcomes. Patients with the precursor lesion, Barrett's oesophagus, are recommended to undergo regular endoscopic surveillance, a process that can be burdensome for patients and health services. Professor Rebecca Fitzgerald's team have developed a tool that may be able to improve Barrett's surveillance. She joins us to discuss her recent prospective real-world implementation study of capsule sponge risk stratification in Barrett’s o...
People in this episode
Guest: Rebecca Fitzgerald
Topics covered
- biomarker risk stratification
- Barrett's oesophagus
- oesophageal adenocarcinoma
- endoscopic surveillance
- healthcare innovation
Keywords
- biomarker
- risk stratification
- capsule sponge
- Barrett's oesophagus
- oesophageal adenocarcinoma
- surveillance
- health services
Mentioned in this episode
Organizations: Professor Rebecca Fitzgerald's team
Books & works: Barrett's oesophagus
More episodes of The Lancet in conversation with
- Louise Chappell and Na’ama Carlin on Personal Cancer Stories
- Susannah Stanway on the London Global Cancer Week
- Carlos Monteiro, Camila Corvalán, and Phil Baker on Ultra-Processed Foods and Human Health
- Presented at ASH: the EPCORE FL-1 study on epcoritamab in follicular lymphoma
- Presented at ESMO: the HARMONi-6 study on a bispecific antibody therapy for squamous NSCLC
- Presented at ESMO: the POTOMAC study on immunotherapy in non-muscle-invasive bladder cancer
Explore listener stats, chart rankings, contacts and more on the The Lancet in conversation with podcast page.